Fingerprint
Dive into the research topics of 'Durable Response of Dabrafenib, Trametinib, and Capmatinib in an NSCLC Patient With Co-Existing BRAF-KIAA1549 Fusion and MET Amplification: A Case Report'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically